Abstract:Objective To investigate the expression and clinical significance of α-SMA and ALDH1 in breast carcinoma. Methods In this study, the breast samples were colleceted from both 182 patients with breast carcinomas and 36 with breast diseases or normal breast tissue. Immunohistochemistry was used to detect the expression of α-SMA and ALDH1 in both breast carcinomas and normal or benign breast tissues. Correlations between α-SMA and ALDH1 with clinical prognosis factors and survival status were analyzed statistically. Results The positive rate of α-SMA was significantly higher in breast carcinomas than in controls (67.6% vs 0 %, P<0.001). The positive rate of ALDH1 was higher in breast carcinomas than in controls (37.9% vs 16.7%,P<0.05). The expression of α-SMA was positively correlated to the expression of ALDH1(P<0.05). α-SMA was associated with tumor size. The expression of α-SMA was higher in the tumor when the size was larger than 2 cm. The high expression rate of ALDH1 was correlated to tumor differentiation, the infiltration of vessel,and distant metastasis(P<0.05). The expression of ALDH1 was higher in poor tumor differentiation,positive vessel infiltration and distant metastasis. The five year's survival were not significantly different between the comparative two subgroup of the expression of α-SMA(P>0.05). The five year's survival was shorter in breast carcinoma patients with high expression of ALDH1 than in those with low expression of ALDH1 (P<0.05). Cox regression analysis demonstrated that the overall survival was related to both the expression of α-SMA and ALDH1, the status of progestin receptor, receiving neoadjuvant chemotherapy or not, tumor recurrence and distant metastasis (P<0.05), they’re all the independent prognosis factors of breast carcinoma. Conclusions Both α-SMA and ALDH1 are potentially related to the generation and progression of breast carcinoma. The high expression of α-SMA was positively related to ALDH1 expression,which means TAFs maybe contribute to the generation of the stemness of breast carcinoma.Thus,detection of the two markers may contribute to the judgment of the grade malignancy, the ability of tumor infiltration and the potency of metastasis.

Expression Of Aldh1 And Tgf Beta 2 In Benign And Malignant Breast Tumors And Their Prognostic Implications

The Expression of Aldehyde Dehydrogenase 1 in Invasive Primary Breast Tumors and Axillary Lymph Node Metastases is Associated with Poor Clinical Prognosis.

Aldehyde Dehydrogenase 1 Expression is Correlated with Poor Prognosis in Breast Cancer

Expression of ALDH 1 in atypical ductal hyperplasia , carcinoma , usual ductal hyperplasia and normal breast duct

RRM1, TUBB3, TOP2A, CYP19A1, CYP2D6: Difference Between Mrna and Protein Expression in Predicting Prognosis of Breast Cancer Patients

The Expression of Aldehyde Dehydrogenase Family in Breast Cancer.

Clinical significance of ALDH1 expression in breast cancer:a Meta analysis

Expression and clinical significance of α-SMA and ALDH1 in breast carcinoma

Aldehyde Dehydrogenase 3A1 is Robustly Upregulated in Gastric Cancer Stem-Like Cells and Associated with Tumorigenesis.

Aldehyde Dehydrogenase 1 Expression Correlates with Clinicopathologic Features of Patients with Breast Cancer: A Meta-Analysis

Aldehyde Dehydrogenases and Cancer Stem Cells.

Expression of Aldehyde Dehydrogenase 1 and Atp-Binding Cassette Superfamily G Member 2 is Enhanced in Primary Foci and Metastatic Lymph Node from Patients with Triple-Negative Breast Cancer

Abstract P2-06-12: The expression of aldehyde dehydrogenase1 in cytoplasm or stroma of breast cancer is associated with clinical prognosis

Distinct prognostic values of ALDH1 isoenzymes in breast cancer

Clinicopathological Significance of ALDH1A1 in Lung, Colorectal, and Breast Cancers: a Meta-Analysis.

ALDH1 is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome.

Increased Expression of ALDH1A1 Protein is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma

Abnormal Expression of the Notch and Wnt/β-catenin Signaling Pathways in Stem-Like ALDHhiCD44+ Cells Correlates Highly with Ki-67 Expression in Breast Cancer

Prognostic Impact of ALDH1 Expression in Transitional Cell Carcinoma of the Renal Pelvis

The Prognostic Roles of Circulating ALDH1(+) Tumor Cell in the Patients with Non-Small Cell Lung Cancer

Studies of correlation between Her-2 and ALDH1 expression in breast cancer